Company Info
Phone(720) 262-7002
Year Established
2017
Ticker
EWTX
Exchange
NASDAQ
Contacts
Kevin Koch, Ph.D.President & CEO
Alan Russell, Ph.D.
Co-Founder & CSO
Michael Carruthers
CFO
Behrad Derakhshan, Ph.D.
CBO
Joanne M. Donovan, M.D., Ph.D.
CMO
John Moore
General Counsel
Robert Blaustein, M.D., Ph.D.
CDO
Company Description
Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.